Feasibility of predicting MCI/AD using neuropsychological tests and serum β-amyloid

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Luis, Cheryl A ^a   Abdullah, Laila ^a   Ait Ghezala, Ghania ^a   Mouzon, Benoit ^a   Keegan, Andrew P ^a   Crawford, Fiona ^a   Mullan, Michael ^a  

^a ROSKAMP INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 80052665736     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/786264     Document Type: Article

References (50)

1. Brookmeyer R., Johnson E., Ziegler-Graham K., Arrighi H. M., Forecasting the global burden of Alzheimer's disease Alzheimer's and Dementia 2007 3 3 186 191 (Pubitemid 46825511)
2. Weimer D. L., Sager M. A., Early identification and treatment of Alzheimer's disease: social and fiscal outcomes Alzheimer's and Dementia 2009 5 3 215 226
3. Holmes C., Boche D., Wilkinson D., Long-term effects of Abeta42 immunisation in Alzheimers disease: follow-up of a randomized, placebo-controlled phase 1 trial Lancet 2008 372 216 223 (Pubitemid 351978111)
4. Blacker D., Lee H., Muzikansky A., Martin E. C., Tanzi R., McArdle J. J., Moss M., Albert M., Neuropsychological measures in normal individuals that predict subsequent cognitive decline Archives of Neurology 2007 64 6 862 871 (Pubitemid 46919842)
5. Bondi M. W., Salmon D. P., Galasko D., Thomas R. G., Thal L. J., Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease Psychology and Aging 1999 14 2 295 303 (Pubitemid 29291565)
6. Amieva H., Le Goff M., Millet X., Orgogozo J. M., Peres K., Barberger-Gateau P., Jacqmin-Gadda H., Dartigues J. F., Prodromal Alzheimer's disease: successive emergence of the clinical symptoms Annals of Neurology 2008 64 5 492 498
7. Small G. W., La Rue A., Komo S., Kaplan A., Mandelkern M. A., Predictors of cognitive change in middle-aged and older adults with memory loss American Journal of Psychiatry 1995 152 12 1757 1764
8. Klunk W. E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D. P., Bergstrm M., Savitcheva I., Huang G. F., Estrada S., Ausén B., Debnath M. L., Barletta J., Price J. C., Sandell J., Lopresti B. J., Wall A., Koivisto P., Antoni G., Mathis C. A., Lngstrm B., Imaging brain amyloid in Alzheimer's disease with pittsburgh compound-B Annals of Neurology 2004 55 3 309 319
9. Small G. W., Kepe V., Ercoli L. M., Siddarth P., Bookheimer S. Y., Miller K. J., Lavretsky H., Burggren A. C., Cole G. M., Vinters H. V., Thompson P. M., Huang S. C., Satyamurthy N., Phelps M. E., Barrio J. R., PET of brain amyloid and tau in mild cognitive impairment New England Journal of Medicine 2006 355 25 2652 2663 (Pubitemid 44969124)
10. Vemuri P., Wiste H. J., Weigand S. D., Shaw L. M., Trojanowski J. Q., Weiner M. W., Knopman D. S., Petersen R. C., Jack C. R., MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change Neurology 2009 73 4 294 301
11. Fagan A. M., Roe C. M., Xiong C., Mintun M. A., Morris J. C., Holtzman D. M., Cerebrospinal fluid tau/ -amyloid (42) ratio as a prediction of cognitive decline in nondemented older adults Archives of Neurology 2007 64 3 343 349 (Pubitemid 46425688)
12. Graff-Radford N. R., Crook J. E., Lucas J., Boeve B. F., Knopman D. S., Ivnik R. J., Smith G. E., Younkin L. H., Petersen R. C., Younkin S. G., Association of low plasma A 42/A 40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer' disease Archives of Neurology 2007 64 3 354 362 (Pubitemid 46425689)
13. Okereke O. I., Xia W., Selkoe D. J., Grodstein F., Ten-year change in plasma amyloid levels and late-life cognitive decline Archives of Neurology 2009 66 10 1247 1253
14. Abdullah L., Luis C., Paris D., Mouzon B., Ait-Ghezala G., Keegan A. P., Wang D., Crawford F., Mullan M., Serum A levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT subcohort Molecular Medicine 2009 15 11-12 432 437
15. Bateman R. J., Wen G., Morris J. C., Holtzman D. M., Fluctuations of CSF amyloid- levels: implications for a diagnostic and therapeutic biomarker Neurology 2007 68 9 666 669 (Pubitemid 46667813)
16. Abdullah L., Paris D., Luis C., Quadros A., Parrish J., Valdes L., Keegan A. P., Mathura V., Crawford F., Mullan M., The influence of diagnosis, intra- and inter-person variability on serum and plasma A levels Neuroscience Letters 2007 428 2-3 53 58 (Pubitemid 350051180)
17. Lachno D. R., Vanderstichele H., De Groote G., The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma beta-amyloid isoforms using the INNO-BIA plasma Abeta forms multiplex assay The Journal of Nutrition, Health and Aging 2009 13 220 225
18. Ertekin-Taner N., Younkin L. H., Yager D. M., Parfitt F., Baker M. C., Asthana S., Hutton M. L., Younkin S. G., Graff-Radford N. R., Plasma amyloid protein is elevated in late-onset Alzheimer' disease families Neurology 2008 70 8 596 606 (Pubitemid 351294637)
19. Thompson P. W., Lockhart A., Monitoring the amyloid beta-peptide in vivocaveat emptor Drug Discovery Today 2009 14 5-6 241 251
20. Meinert C., McCaffrey L., Breitner J., Alzheimer's disease anti-inflammatory prevention trial: design, methods and baseline results Alzheimers Dement 2009 5 93 104
21. Teng E. L., Chui H. C., The modified mini-mental state (MMS) examination Journal of Clinical Psychiatry 1987 48 8 314 318 (Pubitemid 17138128)
22. Brandt J., Benedict R., The Hopkins verbal learning test: development of a new memory test with six equivalent forms Clinical Neuropsychologist 1991 5 2 125 142
23. Wechsler D., Wechsler Adult Intelligence ScaleRevised. Manual 1981 New York, NY, USA Psychological Corporation
24. Wilson B., Cockburn J., Baddeley A., Hiorns R., The development and validation of a test battery for detecting and monitoring everyday memory problems Journal of Clinical and Experimental Neuropsychology 1989 11 6 855 870 (Pubitemid 20052121)
25. Benedict R., Schrectlen C., Groninger L., Revision of the brief visual spatial memory tests: studies of normal performance, reliability and validity Psychological Assessment 1996 10 31 39
26. Folstein M. F., Folstein S. E., McHugh P. R., Mini mental state. A practical method for grading the cognitive state of patients for the clinician Journal of Psychiatric Research 1975 12 3 189 198
27. Yesavage J., Brink T., Rose T., Development and validation of a geriatric depression screening scale: a preliminary report Journal of Psychiatric Research 1983 17 37 49 (Pubitemid 13123113)
28. Squire L., Wetzel C., Slater P., Memory complaints after electroconvulsive therapy: assessment with a new self-rating scale instrument Biological Psychiatry 1979 14 791 801 (Pubitemid 10215218)
29. Clark C. M., Ewbank D. C., Performance of the dementia severity rating scale: a caregiver questionnaire for rating severity in Alzheimer' disease Alzheimer Disease and Associated Disorders 1996 10 1 31 39 (Pubitemid 26073890)
30. de Jager C. A., Schrijnemaekers A. C. M. C., Honey T. E. M., Budge M. M., Detection of MCI in the clinic: evaluation of the sensitivity and specificity of a computerised test battery, the Hopkins verbal learning test and the MMSE Age and Ageing 2009 38 4 455 460
31. Luis C. A., Abdullah L., Paris D., Quadros A., Mullan M., Mouzon B., Ait-Ghezala G., Crawford F., Mullan M., Serum -amyloid correlates with neuropsychological impairment Aging, Neuropsychology, and Cognition 2009 16 2 203 218
32. Tschanz J. T., Welsh-Bohmer K. A., Skoog I., West N., Norton M. C., Wyse B. W., Nickles R., Breitner J. C. S., Dementia diagnoses from clinical and neuropsychological data compared: the cache county study Neurology 2000 54 6 1290 1296 (Pubitemid 30174049)
33. Morris J. C., Heyman A., Mohs R. C., Hughes J. P., Van Belle G., Fillenbaum G., Mellitis E. D., Clark C., The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease Neurology 1989 39 9 1159 1165 (Pubitemid 19239715)
34. Wechsler D., Wechsler Memory ScaleRevised 1987 San Antonio, Tex, USA Psychological Corporation
35. Benton A., Hamsher K., Siven A., Multilingual Aphasia Examination 1994 3rd Iowa City, Calif, USA AJA Associates
36. Sumerall S. W., Timmons P. L., James A. L., Ewing M. J. M., Oehlert M. E., Expanded norms for the controlled oral word association test Journal of Clinical Psychology 1997 53 5 517 521 (Pubitemid 27310294)
37. Reitan R., Trail Making Test: Manual for Administering and Scoring 1986 Tucson, Ariz, USA Reitan Neuropsychological Laboratory
38. Smith A., Symbol Digit Modalities TestManual 1982 Los Angeles, Calif, USA Western Psychological Services
39. Zachary R., Shipley Institute of Living ScaleRevised 1991 Los Angeles, Calif, USA Western Psychological Services
40. McKhann G., Drachman D., Folstein M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease Neurology 1984 34 939 944 (Pubitemid 14076461)
41. Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G., Kokmen E., Mild cognitive impairment: clinical characterization and outcome Archives of Neurology 1999 56 3 303 308 (Pubitemid 29120227)
42. Petersen R. C., Doody R., Kurz A., Mohs R. C., Morris J. C., Rabins P. V., Ritchie K., Rossor M., Thal L., Winblad B., Current concepts in mild cognitive impairment Archives of Neurology 2001 58 12 1985 1992 (Pubitemid 33143977)
43. Whitwell J. L., Petersen R. C., Negash S., Weigand S. D., Kantarci K., Ivnik R. J., Knopman D. S., Boeve B. F., Smith G. E., Jack C. R., Patterns of atrophy differ among specific subtypes of mild cognitive impairment Archives of Neurology 2007 64 8 1130 1138 (Pubitemid 47258072)
44. Abdullah L., Luis C., Paris D., Ait-ghezala G., Mouzon B., Allen E., Parrish J., Mullan M. A., Ferguson S., Wood M., Crawford F., Mullan M., High serum A and vascular risk factors in first-degree relatives of Alzheimer's disease patients Molecular Medicine 2009 15 3-4 95 100
45. Lyketsos C. G., Breitner J. C. S., Green R. C., Martin B. K., Meinert C., Piantadosi S., Sabbagh M., Naproxen and celecoxib do not prevent AD in early results from a randomized clinical trial Neurology 2007 68 21 1800 1808 (Pubitemid 46791392)
46. Gunstad J., Spitznagel M. B., Glickman E., Alexander T., Juvancic-Heltzel J., Walter K., Murray L., α-amyloid is associated with reduced cognitive function in healthy older adults Journal of Neuropsychiatry and Clinical Neurosciences 2008 20 3 327 330
47. Cosention S., Stern Y., Sokolov E., Plasma {beta}-amyloid and cognitive decline. Archives of Neurology. In press
48. Yaffe K., Weston A., Graff-Radford N. R., Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline Journal of the American Medical Association 2011 305 261 266
49. Breitner J. C. S., Onset of Alzheimer's dementia occurs commonly without prior cognitive impairment: results from the Alzheimer's disease anti-inflammatory prevention trial (ADAPT) Alzheimers Dement 2008 4 4, supplement 1 T130 T131
50. Mattsson N., Zetterberg H., Hansson O., Andreasen N., Parnetti L., Jonsson M., Herukka S. K., Van Der Flier W. M., Blankenstein M. A., Ewers M., Rich K., Kaiser E., Verbeek M., Tsolaki M., Mulugeta E., Rosén E., Aarsland D., Jelle Visser P., Schrder J., Marcusson J., De Leon M., Hampel H., Scheltens P., Pirttil T., Wallin A., Eriksdotter Jnhagen M., Minthon L., Winblad B., Blennow K., CSF biomarkers and incipient Alzheimer' disease in patients with mild cognitive impairment Journal of the American Medical Association 2009 302 4 385 393